Cancer

Items 151-160 of 229

per page
Set Descending Direction
  1. DLL1 (mouse):Fc (human) (rec.)
    AG-40A-0148Y
    AG-40A-0148Y-C01010 µg
    CHF 180.00
    AG-40A-0148Y-C05050 µg
    CHF 370.00
    DLL1 (mouse):Fc (human) (rec.)
  2. DLL4 (human):Fc (human) (rec.) (highly active mutant)
    AG-40B-0176
    AG-40B-0176-C01010 µg
    CHF 350.00
    AG-40B-0176-C100100 µg
    CHF 1'080.00
    DLL4 (human):Fc (human) (rec.) (highly active mutant) (AG-40B-0176) binds to mNotch1 with higher affinity than WT DLL4:Fc. Method: Notch1 (mouse):Fc was coated on an ELISA plate at 1μg/ml. After blocking and washing steps, indicated concentrations
  3. DLL4 (mouse):Fc (human) (rec.)
    AG-40A-0145
    AG-40A-0145-C01010 µg
    CHF 130.00
    AG-40A-0145-C05050 µg
    CHF 290.00
    Adipogenesis inhibition of 3T3L1 cells. 3T3L1 cells were maintained in DMEM, supplemented with 10% fetal bovine serum, penicilin-streptomycin. Adipogenesis was initiated by adding 1μM Dexamethasone, 0.5mM IBMX, 10μg/m lnsulin (day 0) until day
  4. DNER (extracellular domain) (mouse):Fc (human) (rec.)
    AG-40A-0177
    AG-40A-0177-C01010 µg
    CHF 230.00
    AG-40A-0177-C05050 µg
    CHF 685.00
  5. DR6 (mouse):Fc (human) (rec.)
    AG-40B-0062
    AG-40B-0062-C05050 µg
    CHF 170.00
    AG-40B-0062-30503 x 50 µg
    CHF 335.00
  6. Fas (human):Fc (human) (rec.)
    AG-40B-0082
    AG-40B-0082-C05050 µg
    CHF 300.00
    AG-40B-0082-30503 x 50 µg
    CHF 600.00
  7. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.
  8. FasL, Soluble (human) (rec.)
    AG-40B-0001
    AG-40B-0001-C01010 µg
    CHF 190.00
    AG-40B-0001-30103 x 10 µg
    CHF 385.00
  9. Fc (human):FasL, Soluble (human) (rec.)
    AG-40B-0132
    AG-40B-0132-C01010 µg
    CHF 335.00
    AG-40B-0132-30103 x 10 µg
    CHF 670.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of MegaFasL, Soluble (human) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Pr
  10. Fc (human):FGL1 (mouse) (rec.)
    AG-40B-0185
    AG-40B-0185-C01010 µg
    CHF 240.00
    AG-40B-0185-30103 x 10 µg
    CHF 480.00
    AG-40B-0185-C100100 µg
    CHF 1'140.00

Items 151-160 of 229

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.